Merck & Co. / CLS Bank Int’l / MOLECULAR PATHOLOGY V. MYRIAD GENETICS INC. / GeneDx Ltd. / Funk Brothers Seed Co. / In Merck & Co. / Parke-Davis & Co. / MySpace Inc. / Gene Ltd. / CLS Bank International / Elberfeld Co. / Badische / GraphOn Corp. / Prometheus Labs. / Merck / Fibre Disintegrating Co. / H.K. Mulford Co. / Kalo Inoculant Co. / Olin Mathieson Chemical Corp. / Alice Corp. / Ambry Genetics Corp. / American Wood-Paper Co. / Gene-By-Gene Inc. / Myriad Genetics Inc. / /
Country
United States / /
Event
FDA Phase / /
Facility
University of California / /
IndustryTerm
natural product / basic tools / biotechnology / chemical formula / pharmaceutical industry / ineligible natural products / natural products / chemical elements / purified natural product / crude oil / chemical properties / chemical possessed new properties / biotechnology industry / chemical industry / chemical changes / biotechnology revolution / patent law / biotechnology industry uses living cells / water digest oil spills / chemical structure / chemical bonds / /
MedicalCondition
pernicious anemia / tumor / /
Organization
Association for Molecular Pathologists / Supreme Court / U.S. Patent and Trademark Office / School of Law / Court of Customs and Patent Appeals / University of California / Berkeley / American Civil Liberties Union / Univ. of Utah Research Found. / Chakrabarty Court / Patent Office / United Nations / UN Court / US Federal Reserve / Myriad Court / Merck court / /
Person
Learned Hand / However / Eric J. Rogers / Dennis Crouch / Peter S. Menell / Esteban Burrone / Christopher Beauchamp / Richard Seth Gipstein / Kyle Jensen / Emma Barraclough / Mayo Collaborative Servs / Fiona Murray / Rader / Bill Malone / Dan Burk / Sandra S. Park / Leslie A. Demers / /
Position
General / King / Chief Judge / Commissioner / Judge / /
Product
BRCA1 / /
ProvinceOrState
California / /
PublishedMedium
BERKELEY TECHNOLOGY LAW JOURNAL / LAW REVIEW / /
TVStation
Kalo / /
Technology
394 C. BERKELEY TECHNOLOGY / Biotechnology / html / 386 BERKELEY TECHNOLOGY / human genome / 74 390 BERKELEY TECHNOLOGY / 392 BERKELEY TECHNOLOGY / 388 BERKELEY TECHNOLOGY / recombinant DNA / /
ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS, INC.: THE PRODUCT OF NATURE DOCTRINE REVISITED Tup Ingram † In a highly anticipated decision that overturned two decades of U.S. Patent and Trademark Office (“U